Jonatan Barrera‐Chimal

The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling

Jonatan Barrera‐Chimal, Gabriel Rufino Estrela, Sébastian Lechner et al. · Kidney International · 2018 · 160 citations

Inflammation, Macrophage Interleukin-4 Receptor, Myeloid Mineralocorticoid Receptor +14

Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Protects Against Acute Kidney Injury–Mediated Chronic Kidney Disease

Lionel Lattenist, Sébastian Lechner, Smail Messaoudi et al. · Hypertension · 2017 · 120 citations · Full text

Inflammation, Bilateral Ischemia, Renal Function +12

Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury

Jonatan Barrera‐Chimal, Rosalba Pérez‐Villalva, Roxana Rodríguez‐Romo et al. · Kidney International · 2012 · 114 citations

Inflammation, Urology, Renal Function +9

AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease

Roxana Rodríguez‐Romo, Kenia Benítez, Jonatan Barrera‐Chimal et al. · Kidney International · 2015 · 88 citations · Full text

Inflammation, Urology, Renal Function +12

Benefit of Mineralocorticoid Receptor Antagonism in AKI: Role of Vascular Smooth Muscle Rac1

Jonatan Barrera‐Chimal, Gwennan André‐Grégoire, Aurélie Nguyen Dinh Cat et al. · Journal of the American Society of Nephrology · 2017 · 82 citations · Full text

Vascular Disease, Renal Inflammation, Oxidative Stress +21